Advertisement Press Releases Archive - Page 174 of 233 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pressreleases

  • New CenterWatch Report Finds U.S. Investigative Site Market Ripe for Consolidation Driven by European SMOs

    CenterWatch today reports that the fragmented U.S. investigative site market is poised for acquisitions that may be driven by the most unlikely of sources: large European site management organizations (SMOs). The report, released in the January issue of The CenterWatch Monthly, provides an in-depth look at the infrastructure and strategies of the European companies likely to drive this wave of consolidation. The report signals opportunity and change for clinical research professionals in the U.S.

  • CenterWatch Launches Virtual News Hub for Clinical Research Professionals

    CenterWatch, a leading publisher of clinical trials information, announced today that it has launched its next-generation virtual news site, CenterWatch News Online. This dynamic, easy-to-navigate, real-time online service features objective news reports covering timely stories and emerging trends in the global clinical research industry.

  • Flexible, High Performance Solvent Evaporators

    HT Series II Solvent Evaporators from Genevac offer leading edge features that provide superior sample protection, flexibility for multiple applications, consistency of results, robust build quality, ease-of-use, rapid high-throughput results and low maintenance.

  • CenterWatch Expands its www.centerwatch.com Service to Assist Patients and Health Care Professionals in Finding Clinical Trials

    CenterWatch—a leading publisher of clinical trials information—announced that it has more than quadrupled the size of its Clinical Trials Listing Service™ (CTLS). The service now lists more than 80,000 active clinical trials across a wide range of disease conditions, making it the largest online and dynamic database of global clinical trials involving new drugs and devices regulated by the Food and Drug Administration and the Department of Health and Human Services. The listings are accessible free-of-charge for patients, the public and health care professionals.

  • CenterWatch Publishes New, Expanded Guides for CRAs and CRCs

    CenterWatch, a leading publisher in the clinical trials industry, announced today the release of newly revised and expanded editions of two of its top-selling training resources—The CRA’s Guide to Monitoring Clinical Trials, 3rd Edition, and The CRC’s Guide to Coordinating Clinical Trials, 2nd Edition.

  • Stay Cool

    Exposure to extreme temperatures in transit can reduce the efficacy of pharmaceutical products. Niclas Ohlsson, TSS AB, explains to Rod James how a company-wide approach to temperature monitoring can result in greater efficiency, improved risk management and reduced costs.

  • Alliance Life Sciences Releases White Paper: “State and Federal ‘Sunshine Acts’ Shift Key Opinion Leader Marketing Tactics”

    Alliance Life Sciences Consulting Group (ALSCG), a leading management and technology consultancy, in a white paper released today, concludes that "State and Federal Sunshine Acts Shift KOL Marketing Tactics" by helping to identify and prosecute abusive and/or illegal remuneration that firms and academic institutions have practiced in return for product endorsements by Key Opinion Leader (KOL) physicians -- without sufficient regard for their relative product safety, clinical efficacy and cost.